Nuclear medicine pharmacy firm Syncor reported solid financialresults for its 1995 fiscal year (end-December), offering furtherproof that the nuclear medicine industry's slump eased last year.The Chatsworth, CA, firm said that both revenues and
Nuclear medicine pharmacy firm Syncor reported solid financialresults for its 1995 fiscal year (end-December), offering furtherproof that the nuclear medicine industry's slump eased last year.The Chatsworth, CA, firm said that both revenues and earningswere up and the company had achieved its financial objectives.
For 1995, Syncor had revenues of $332.5 million, up 4% comparedwith $320 million in 1994. Net income last year stood at $4.7million, up sharply from $1.2 million the year before.
For the fourth quarter, Syncor reported net income of $1.1million on revenues of $85.1 million. In 1994, the company hada loss of $537,000 on sales of $81.7 million.
Syncor said that the improved numbers were due to cost controlprograms, a better product mix, and successful efforts to manageradiopharmaceutical pricing. Cardiology sales continue to driverevenue growth, with sales from cardiology products accountingfor 63% of the company's business in 1995, up from 56% in 1994.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.